RhBMP-2-loaded calcium phosphate cement scaffold combined with autogenous bone grafting in the treatment of limbs nonunion&nbsp;

doi:10.13418/j.issn.1001-165x.2020.02.020

Chinese Journal of Clinical Anatomy ›› 2020, Vol. 38 ›› Issue (2) : 202-207. DOI: 10.13418/j.issn.1001-165x.2020.02.020

RhBMP-2-loaded calcium phosphate cement scaffold combined with autogenous bone grafting in the treatment of limbs nonunion

WU Hao-jun¹, Tan Rong-xiong¹，HE Yan-xia², CHEN Hang¹, LIU Yan-Zhi³, LIN Han¹, WEI Bo¹, ZHENG Yue-yu¹

Author information +

History +

Abstract

Objective　To investigate the clinical effect of recombinant human bone morphogenetic protein 2(CPC/rhBMP-2)-loaded calcium phosphate cement scaffold combined with autogenous bone graft in the treatment of non-infectious atrophy type limbs nonunion.　Methods　A total of 16 patients (12 males, 4 females; aged from 16ys to 67ys, mean age: 37.06±16.31 ys) with limbs nonunion after surgical treatment of fractures from September 2013 to September 2017 were analyzed retrospectively. Bone nonunion part were lower limbs (tibia 5 cases, femur 3 cases, calcaneus 1 case, fibula 1 case) and upper limbs (radius 3 cases, clavicle 1 case, scaphoid 1 case). All patients were treated with CPC/rhBMP-2 scaffold combined with autogenous bone grafting in the center of bone defect. Follow-up patients were treated with X-ray to observe the fractures healing after operation and record the complication till fractures healed. Upper extremity dysfunction assessment scale (DASH), lower extremity function scale (LEFS) and SF-12 quality of life scale were used to evaluate the effect pre- and post-treatment.　Results　Mean follow-up period was 16.93±4.06 months (ranged from 12 to 26 months). X-ray film showed that all fractures were healed, healing time was 3~10 months (mean 5.43±2.25 months). There were statistical difference between preoperative and postoperative DASH, LEFS and SF-12 scale (P<0.05).　Conclusions　CPC/rhBMP-2 combined with autogenous bone graft are effective and safe in the treatment of non-infectious atrophy type limbs nonunion.

Key words

Autogenous bone grafting / / / Atrophic nonunion / 　Osteoinductive membrane / / / Calcium phosphate / / / Bone morphogenetic protein

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

WU Hao-jun, Tan Rong-xiong, HE Yan-xia, CHEN Hang, LIU Yan-Zhi, LIN Han, WEI Bo, ZHENG Yue-yu. RhBMP-2-loaded calcium phosphate cement scaffold combined with autogenous bone grafting in the treatment of limbs nonunion [J]. Chinese Journal of Clinical Anatomy. 2020, 38(2): 202-207 https://doi.org/10.13418/j.issn.1001-165x.2020.02.020

References

[1] Kodera T, Tada H, Akazawa A, et al. Evaluation of the use of Calcium Phosphate cement for aesthetic neurosurgical cranial reconstruction[J]. World Neurosurg, 2018, 110:296-304.
[2] Catros S, Zwetyenga N, Bareille R, et al. Subcutaneous-induced membranes have no osteoinductive effect on macroporous HA-TCP in vivo[J]. J Orthop Res, 2009, 27(2):155-161.
[3] Sasaki G, Watanabe Y, Miyamoto W, et al. Induced mem- brane technique using beta-tricalcium phosphate for reconstruction of femoral and tibial segmental bone loss due to infection: technical tips and preliminary clinical results[J]. Int Orthop, 2018, 42(1):17-24.
[4] Gupta S, Malhotra A, Jindal R, et al. Role of Beta Tri-calcium Phosphate-based Composite Ceramic as Bone-Graft Expander in Masquelet's-Induced Membrane Technique[J]. Indian J Orthop, 2019, 53(1):63-69.
[5] Goldberg VM, Stevenson S. Natural history of autografts and allografts[J]. Clin Orthop Relat Res, 1987, (225):7-16.
[6] Lin D, Zhang J, Bai F, et al. Fabrication and clinical application of easy-to-operate pre-cured CPC/rhBMP-2 micro-scaffolds for bone regeneration[J]. Am J Transl Res, 2016, 8(3):1379-1396.
[7] Frölke JP, Patka P. Definition and classification of fracture non-unions[J]. Injury, 2007, 38(2):19-22.
[8] Hudak PL, Amadio PC, Bombardier C. Development of an upper extremity outcome measure: the DASH (disabilities of the arm,shoulder and hand). The upper extremity collaborative group (UECG) [J]. Am J Ind Med, 1996, 29(6):602-608.
[9] Binkley JM, Stratford PW, Lott SA, et al. The lower extremity functional scale (LEFS): scale development, measurement properties, and clinical application. North American Orthopaedic rehabilitation research network[J]. Phys Ther,1999, 79(4):371-383.
[10]Ware J, Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity[J]. Med Care,1996, 34(3):220-233.
[11]Alam QS, Alam MT, Reza MS, et al. Evaluation of outcome of exchange nailing with autogenous bone graft for treating aseptic nonunion of femoral shaft fracture[J]. Mymensingh Med J, 2019, 28(2):378-381.
[12]Parent M, Baradari H, Champion E. Design of calcium phosphate ceramics for drug delivery applications in bone diseases: A review of the parameters affecting the loading nd release of the therapeutic substance[J]. J Control Release,2017, 252:1-17.
[13]Kolk A, Boskov M, Haidari S, et al. Comparative analysis of bone regeneration behavior using recombinant human BMP-2 versus plasmid DNA of BMP-2[J]. J Biomed Mater Res A, 2019,107(1):163-173.
[14]Masquelet A, Kanakaris NK, Obert L, et al. Bone Repair Using the Masquelet Technique[J]. J Bone Joint Surg Am, 2019,101(11):1024-1036.
[15]Singh KA, Burstein FD, Williams JK. Use of hydroxyapatite cementin pediatric craniofacial reconstructive surgery: strategies foravoiding complications[J]. J Craniofac Surg, 2010, 21(4):1130-1135.
[16]Hernigou P, Dubory A, Pariat J, et al. Beta-tricalcium phosphate for orthopedic reconstructions as an alternative to autogenous bone graft[J]. Morphologie, 2017, 101(334):173-179.